Agreement for Purchase of Biological Materials between Safetek International, Inc. and Serapis Technologies Inc. & Serapis Biotech Ltd.

Contract Categories: Business Finance › Purchase Agreements
Summary

Safetek International, Inc. agrees to purchase certain biological materials from Serapis Technologies Inc. and Serapis Biotech Ltd. for a total price of $100,000 plus VAT. $30,000 of this amount will be paid by waiving repayment of a previous bridge loan, while the remaining $70,000 will be paid in 12 equal monthly installments starting on the signing date. The transfer of the biological materials will follow the terms set out in a prior extension agreement. All parties have agreed to these terms by signing the document.

View More
EX-10.4 2 v039016_ex10-4.txt EXHIBIT 10.4 Safetek International, Inc. March 27, 2006 To: Serapis Technologies Inc. ("Serapis US") Serapis Biotech Ltd. ("Serapis Israel") Dear Sirs, Re: Purchase of Biological Material On ____ the undersigned has executed Term Sheet (the "Term Sheet") with Serapis US and Serapis Israel (collectively, "Serapis"), which was extended on November 30, 2005 (the "Extension"). Pursuant to the provisions of Section 5 of the Extension, this is to inform you that we decided to exercise the right granted to us under the Extension and to purchase from Serapis the Biological Materials (as defined in Section 5 of the Extension), against payment of total of US$ 100,000 plus VAT (the "Purchase Price"). 30,000US$ of the Purchase Price will be paid by the undersigned by waiving Serapis obligations to repay the Bridge Loan provided by the undersigned to Serapis pursuant to the Term Sheet. The Balance of the Purchase Price, in the amount of US$70,000, will be paid to Serapis in 12 equal monthly payments, with the first payment on the signing date. The Biological Materials will be transferred to us pursuant to the additional terms and conditions set forth in Section 5 of the Extension. Please indicate your agreement with your signature hereunder. Sincerely yours, Safetek International, Inc. We agree: /s/ Vered Caplan Serapis Technologies Inc. /s/ Vered Caplan Serapis Biotech Ltd. -4-